Early Pregnancy Serum Ferritin Levels as a Predictor for Gestational Diabetes Mellitus
High Serum Ferritin Early in Pregnancy May Predict the Development of Gestational Diabetes Later.
1 other identifier
observational
556
1 country
1
Brief Summary
This prospective study evaluates a target population of pregnant women at the time of pregnancy diagnosis to investigate the predictive value of serum ferritin (SF) levels for the later development of gestational diabetes mellitus (GDM). The intervention involves measuring early-pregnancy SF, transferrin, and hemoglobin levels, alongside HbA1c, and comparing these biomarkers between women who later develop GDM and those who remain normoglycemic. The primary outcome is to assess the success rate of this diagnostic regimen in identifying high-risk individuals, aiming to establish SF as a valuable early biomarker for GDM to enable timely interventions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 5, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 7, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 10, 2025
CompletedFirst Submitted
Initial submission to the registry
February 20, 2026
CompletedFirst Posted
Study publicly available on registry
February 25, 2026
CompletedFebruary 25, 2026
February 1, 2026
2 years
February 20, 2026
February 20, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Success Rate of Diagnostic Regimens in Predicting Gestational Diabetes Mellitus
The efficacy of early pregnancy Serum Ferritin (SF) levels in accurately identifying women who will subsequently meet the diagnostic criteria for GDM.
24-28 weeks gestation
Secondary Outcomes (1)
Iron Homeostasis Markers
24-28 weeks gestation
Study Arms (2)
GDM Group
Pregnant women who develop gestational diabetes mellitus later in pregnancy.
Non GDM Group
Pregnant women who maintain normal glucose tolerance throughout pregnancy.
Interventions
Fasting blood glucose (FBG), 2-h Post postprandial blood glucose (PPBG), HbA1c, and Fasting Serum Insulin (FSI).
Eligibility Criteria
Pregnant women at the time of their initial pregnancy diagnosis, typically presenting at prenatal or outpatient clinics.
You may qualify if:
- Confirmed pregnancy at an early gestational age.
- Provision of clinical and family history (e.g., age, BMI, history of GDM).
You may not qualify if:
- Pre-existing Type 1 or Type 2 Diabetes Mellitus.
- Conditions known to significantly alter iron metabolism independent of pregnancy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Benha University
Banhā, Al Qalyoubia, 13511, Egypt
Biospecimen
Venous blood samples were drawn aseptically from the antecubital vein for molecular and biochemical analysis. Sample Types \& Collection: Fluoride-containing tubes: Used for blood samples intended for Fasting Blood Glucose (FBG) and 2-hour postprandial blood glucose (PPBG) estimation. EDTA-containing tubes: Used for blood samples intended for HbA1c estimation. Serum Processing: Blood was collected in clean tubes, allowed to clot, and centrifuged at 1000 rpm for 10 minutes to separate the serum. Storage Conditions: Serum Storage: Samples were kept frozen at -20 °C for the later estimation of insulin, ferritin, iron, and Total Iron-Binding Capacity (TIBC) via ELISA. Laboratory Parameters Measured: Glycemic Markers: FBG, 2-h PPBG, HbA1c, and Fasting Serum Insulin (FSI). Iron Indices: Serum ferritin, serum iron, TIBC, transferrin saturation (TF), and hemoglobin concentration
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Obestitrics and gynecology
Study Record Dates
First Submitted
February 20, 2026
First Posted
February 25, 2026
Study Start
December 5, 2022
Primary Completion
December 7, 2024
Study Completion
October 10, 2025
Last Updated
February 25, 2026
Record last verified: 2026-02